Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,411.20
(
-2.35%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,178.42
(
-0.24%
)
News Focus
News Focus
Post# of 257300
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: DewDiligence post# 169323

Tuesday, 11/05/2013 7:45:51 AM

Tuesday, November 05, 2013 7:45:51 AM

Post# of 257300
NVS-ENTA HCV program in GT2/3?



Here's a GT2/GT3 dose escalation study of Alisporivir in combination with Riba. The abstract I posted appears to hint at a NS5A inhibitor combination.




http://clinicaltrials.gov/ct2/show/NCT01970904?term=Alisporivir&rank=5
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up